Navigation Links
Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
Date:3/11/2008

BRAINTREE, Mass., March 11 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today the appointment of Peter Allen to the newly created position of Chief Marketing Officer. In this position, Mr. Allen will assume responsibility for global marketing of Haemonetics' full product portfolio in addition to his current responsibilities as President, Donor Division.

Brian Concannon, Chief Operating Officer, commented, "Pete Allen was an architect of our strategic vision to be the global leader in blood management solutions for our customers. He has established strong relationships with our customers and gained keen insight into customer needs and market trends. We are pleased that he will be leading Haemonetics' marketing strategy as we leverage the Haemonetics brand in our expanding markets."

Through its blood management solutions offerings, Haemonetics markets to hospitals, blood banks, and plasma collection customers. Haemonetics' marketing efforts support improving patient care as it relates to blood transfusions while simultaneously reducing total healthcare costs.

Mr. Concannon added, "Haemonetics is uniquely qualified to offer a full suite of business solutions related to blood management. We are the only company that operates across the blood supply chain from the blood donor to the patient transfusion. As importantly, we are the only company that offers the depth of products, through our devices, services, and software solutions, required to truly meet our customers' blood management needs. Under Pete Allen's leadership, we will drive a cohesive, global message of blood management solutions for our customers."

Mr. Allen, age 49, joined Haemonetics in 2003 as President, Donor Division. He has over twenty five years experience in health care and medical products. Prior to joining Haemonetics, Mr. Allen was Vice President of The Aethena Group, a private equity firm providing services to the global healthcare industry. From
'/>"/>

SOURCE Haemonetics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...all/--IES(Nasdaq: IESC ),aleadingnationalprovidero...hecommercial,industrialandresidentialmarkets,annou...dedacontractfromManhattanTorconJVtoinstalltheelect...ementfacilityattheU.S.ArmyMedicalResearchInstitute...rick,Md. ,, ThenewUSAMRIIDreplacementfacilitywi...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D...NasdaqStockMarketthattradinginthecompany,scommonst...SEwillbefiledwiththe,SecuritiesandExchangeCommissi...nNasdaq,unlessthecompanyfilesanappealtotheNasdaq,L...appeal,which,willstaythesuspensionanddelistingthro...
(Date:11/24/2009)...e-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abioph...lizingnovelpainmanagementtherapies,announcedtodayt...r,isscheduledtopresentatthe21stAnnualPiperJaffrayH...ewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTon...availabletorespondtoquestionsduringthepresentation...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-...ofadvancedlasersystemsandinstrumentsforthestemcell...rationalandfinancialresultsforthethirdquarterended...s$1.46millioncomparedwith$1.43millioninQ32008,-Gro...tinQ3,2008,-Netlossreducedto$148,000comparedto$283...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...P.A., Deliver Faster Recovery,Fewer Complications ....J., Aug. 5 Thoracic Group, P.A., (http://www.tho...urgical services,and a national leader of minimall... has announced the successful completion of its 5,...n its ability to reduce incision,size, hospital st...
... of,the Sigma-Aldrich Group (Nasdaq: SIAL ), toda...e President of Quality and Regulatory Affairs, eff...and operations professional with,nearly 25 years e...ce team,and oversee all aspects of the Company,s r...report to SAFC President, Dr. Frank Wicks, and to ...
...ation,(Nasdaq: MNKD ) will release its 2008 secon...2008 at 4:00 p.m. EDT., Management of the Company... quarter financial results, clinical progress and ...day, August 11, 2008. Presenting from,the Company ...Alfred Mann;,President and Chief Operating Officer...
Other Biology Technology:Renowned NJ-Based Video Assisted Thoracic Surgery (VATS) Team Completes 5,000th Successful Procedure 2Renowned NJ-Based Video Assisted Thoracic Surgery (VATS) Team Completes 5,000th Successful Procedure 3SAFC Appoints New Vice President of Quality and Regulatory Affairs 2SAFC Appoints New Vice President of Quality and Regulatory Affairs 3MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008 2
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/24/2009)...ailable in Spanish . , The presence of incr...lammatory substances in the blood, hinders the los...search project of the University of Navarra conduc...e School of Pharmacy. , The project, entitled "A...o the control of body weight and inflammation," ex...
(Date:11/23/2009).... November 23, 2009 Applied mathematicians disse...ancifolia ), a characteristic long leaf with a sad... along the edges. The simple cause of the lily,s f...ding during differential growthwas revealed by usi...bbons. , Haiyi Liang, a postdoctoral student at ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Induced Labor May Improve Outcome in Risky Pregnancies 53554 1Induced Labor May Improve Outcome in Risky Pregnancies 53554 2Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 1Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 2Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 1Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 2Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 3Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 4Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 5Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 6Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 7Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 8Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 9Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 10Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 11Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 12Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 13Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 14Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 15
... today that they have entered into a non-exclusive...ovide Affymetrix customers with new software solut...s agreement, Stratagene will develop a new softwar...ch will be offered as a standard statistical analy...rays. , In April 2005, Affymetrix will make ArrayA...
...ol have discovered how fish have evolved over the ...rent water depths. , A research team led by Dr Mi...e School of Biological Sciences, has revealed how ...a way of floating at certain water levels using a ...ed the mechanism that allows fishes to keep the sw...
... Center are analyzing the surprising results of th... the Amazonian rainforest. , From January 2000 to ...e (2.2 acre) plot in the middle of the Tapajós Nat...fall was diverted with six thousand 2, by 6, clear...oil. The panels were removed during the five-month...
Other Biology News:Affymetrix and Stratagene Announce Strategic Software Alliance 2Scientists discover how fish evolved to float at different sea depths 2World's largest rainforest drying experiment completes first phase 2World's largest rainforest drying experiment completes first phase 3
Mouse Anti-DAP Kinase 1 Monoclonal Antibody, Unconjugated, Clone DAPK-55 from Abcam
Rat IgG2b Clone: A95-1, Allophycocyanin Conjugated/Tagged from BD Biosciences Pharmingen
Rabbit Anti-Human Sphingosine 1-phosphate receptor Edg-1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rat Albumin EIA Kit from Cayman Chemical
Biology Products: